PROF
Profound Medical Corp

404
Mkt Cap
$298.32M
Volume
118,609.00
52W High
$8.95
52W Low
$3.76
PE Ratio
-6.15
PROF Fundamentals
Price
$8.22
Prev Close
$8.34
Open
$8.39
50D MA
$7.10
Beta
0.83
Avg. Volume
155,023.64
EPS (Annual)
-$1.12
P/B
7.72
Rev/Employee
$75,211.27
Loading...
Loading...
News
all
press releases
Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock?
Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Strength Seen in Ocular Therapeutix (OCUL): Can Its 6.1% Jump Turn into More Strength?
Ocular Therapeutix (OCUL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·5d ago
News Placeholder
Profound Medical (TSE:PRN) Trading 2.1% Higher - Still a Buy?
Profound Medical (TSE:PRN) Trading 2.1% Higher - What's Next...
MarketBeat·24d ago
News Placeholder
Profound Medical (NASDAQ:PROF) Shares Down 1.8% - Should You Sell?
Profound Medical (NASDAQ:PROF) Shares Down 1.8% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Profound Medical (TSE:PRN) Stock Price Down 2.6% - What's Next?
Profound Medical (TSE:PRN) Trading Down 2.6% - What's Next...
MarketBeat·1mo ago
News Placeholder
Wall Street Analysts Think Profound Medical (PROF) Could Surge 82.37%: Read This Before Placing a Bet
The consensus price target hints at an 82.4% upside potential for Profound Medical (PROF). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·2mo ago
News Placeholder
Profound Medical (PROF) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
After losing some value lately, a hammer chart pattern has been formed for Profound Medical (PROF), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Zacks·2mo ago
News Placeholder
Profound Medical (PROF) Just Flashed Golden Cross Signal: Do You Buy?
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
Zacks·2mo ago
News Placeholder
Profound Medical (NASDAQ:PROF) Raised to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Profound Medical from a "sell" rating to a "hold" rating in a research report on Sunday...
MarketBeat·2mo ago
News Placeholder
Profound Medical (PROF) Upgraded to Buy: What Does It Mean for the Stock?
Profound Medical (PROF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks·2mo ago
<
1
2
...
>

Latest PROF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.